Heart disease is one of the leading causes of death worldwide, and atrial fibrillation is becoming increasingly common affecting millions of people around the world. Atrial fibrillation is an irregular heartbeat that can increase the risk of stroke and heart failure. Many people suffer from this condition, and it requires ongoing management. To help patients manage their atrial fibrillation and reduce the risk of stroke, a new device called a watchman implanthas been developed. This device is revolutionizing the way patients are treated and reducing the risks associated with the condition.
What Is the Watchman Device?
The Watchman device is a small device that is implanted inside the heart. It was approved by the FDA in 2015 and has been used globally since then. It is a non-surgical procedure that provides an alternative to anticoagulant medications. The device is designed to reduce the risk of stroke in patients with atrial fibrillation who are not suitable candidates for oral anticoagulant therapy.
How Does the Watchman Device Work?
The Watchman device works by closing off the left atrial appendage of the heart, where blood clots often form in patients with atrial fibrillation. The device is inserted into the heart through a vein in the groin, and then guided to the left atrial appendage, where it is deployed. Once in place, it prevents blood clots from forming and reduces the risk of stroke. Over time, the device becomes incorporated into the heart tissue and is no longer visible on imaging scans.
Who Is a Candidate for the Watchman Device?
Not all patients with atrial fibrillation are candidates for the Watchman device. A team of physicians will evaluate the patient to determine their eligibility for the procedure. Typically, patients who cannot tolerate anticoagulant medications or have a high risk of bleeding are good candidates for the Watchman device. The device may also be suitable for patients who are elderly or have other comorbidities that make them unsuitable for anticoagulant therapy.
What Are the Benefits and Risks of the Watchman Device?
The Watchman device has several benefits for patients with atrial fibrillation. These include a reduced risk of stroke, easier management of the condition, and a lower risk of bleeding. As with any medical procedure, there are risks involved, but these are typically low. The most common risks associated with the Watchman device are bruising and bleeding at the site of implantation. However, these risks are low, and the device has been shown to be safe and effective in clinical studies.
If you have atrial fibrillation and are looking for an alternative to anticoagulant medications or are unable to tolerate them, the Watchman device may be a suitable alternative. This device is a non-surgical procedure that is quick, safe, and effective in reducing the risk of stroke for patients with atrial fibrillation. Speak to your physician about the option of the Watchman device to manage your condition safely and securely. Stay secure with the Watchman device, and live a more comfortable and healthy life.